VitaSpring Biomedical Ratios and Metrics

Market cap in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 11, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021
Market Capitalization	2	31	3,105	3,083	2,891	729
Market Cap Growth	-	-99.00%	0.72%	6.64%	296.72%	3083.35%
Enterprise Value	2	31	3,106	3,084	2,892	729
Last Close Price	0.01	0.15	15.00	14.93	14.00	12.00
PE Ratio	-	-	-	-	3178.77	-
PS Ratio	-	-	-	-	515.09	2936.35
PB Ratio	-0.57	-7.73	-926.95	-1286.61	1832.78	7563.02
P/TBV Ratio	-	-	-	-	1832.78	7563.02
EV/Sales Ratio	-	-	-	-	515.14	2936.35
EV/EBITDA Ratio	-	-	-	-	2547.59	-
EV/EBIT Ratio	-	-	-	-	2566.49	-
Debt / Equity Ratio	-	-	-0.03	-0.11	0.29	-
Debt / EBITDA Ratio	-	-	-	-	0.38	-
Net Debt / Equity Ratio	0	0	-0.02	-0.10	0.23	-0.47
Net Debt / EBITDA Ratio	0	0	-0.06	-0.06	0.31	0.11
Net Debt / FCF Ratio	0.02	0.02	-2.00	-3.01	-1.04	1.08
Asset Turnover	-	-	-	-	2.96	-
Quick Ratio	0	0	0.01	0.13	1.76	0.49
Current Ratio	0	0	0.01	0.14	1.76	2.04
Return on Equity (ROE)	-	-	-	-	108.68%	-882.87%
Return on Assets (ROA)	-560.17%	-560.17%	-153.34%	-119.50%	37.13%	-
Return on Invested Capital (ROIC)	-	-	-	-	74.30%	-833.32%
Return on Capital Employed (ROCE)	16.90%	16.90%	33.10%	181.40%	60.40%	-440.70%
Earnings Yield	-33.72%	-2.50%	-0.04%	-0.14%	0.03%	-0.06%
FCF Yield	-	-0.05%	-0.00%	-0.00%	-0.01%	-0.01%
Buyback Yield / Dilution	-	-	-0.25%	-0.26%	-126.13%	-67.11%